HomeInsightsStock Comparison

Saroja Pharma Industries India Ltd vs Vadilal Enterprises Ltd Stock Comparison

Saroja Pharma Industries India Ltd vs Vadilal Enterprises Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Saroja Pharma Industries India Ltd is ₹ 40 as of 22 Jul 15:30.
  • The P/E Ratio of Saroja Pharma Industries India Ltd changed from 16.1 on March 2024 to 16.1 on March 2024 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Vadilal Enterprises Ltd changed from 183.5 on March 2021 to 43.6 on March 2024 . This represents a CAGR of -30.18% over 4 years.
  • The Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 14.11 crore on March 2024 to ₹ 14.11 crore on March 2024 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Vadilal Enterprises Ltd changed from ₹ 88.15 crore on March 2020 to ₹ 327.23 crore on March 2024 . This represents a CAGR of 29.99% over 5 years.
  • The revenue of Saroja Pharma Industries India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Vadilal Enterprises Ltd for the Mar '25 is ₹ 225.67 crore as compare to the Dec '24 revenue of ₹ 137.03 crore. This represent the growth of 64.69%.
  • The ebitda of Saroja Pharma Industries India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Vadilal Enterprises Ltd for the Mar '25 is ₹ -6.06 crore as compare to the Dec '24 ebitda of ₹ -18.36 crore. This represent the decline of -66.99%.
  • The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Vadilal Enterprises Ltd changed from ₹ 10.49 crore to ₹ -8.76 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vadilal Enterprises Ltd changed from 4.89 % on March 2022 to 1.72 % on March 2024 . This represents a CAGR of -29.41% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Saroja Pharma Industries India Ltd

  • Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
  • Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

About Vadilal Enterprises Ltd

  • Vadilal Enterprises Ltd was incorporated in the year 1985.
  • The Company is engaged in the marketing and distribution of the ice cream, dairy products,frozen desserts and process food products of the brand 'Vadilal' all over India except ice cream, dairy product and frozen desserts in Maharashtra, Goa, Karnataka, Kerala, Andhra Pradesh & Telangana. During the year 2008-09, the company's ice cream division introduced new products, namely Custard Apple Pulp, Pine Apple Pieces and Green Gram and Baan & Kulcha (Re-launched RTS Curries and improved Half Cooked Parathas).
  • This division also made special efforts to strengthen their network in the states Chhattisgarh and Maharashtra by appointing new distributors and enhancing the sales of the existing distributors. During the year 2010, the company's forex division started preparation of FOREX Risk Management Policy for the largest corporate level companies.

Saroja Pharma Industries India Ltd News Hub

News

Saroja Pharma Industries India to conduct board meeting

Saroja Pharma Industries India will hold a meeting of the Board of Directors of the Compan...

Read more

24 May 2025 14:03

News

Saroja Pharma Industries India schedules board meeting

Saroja Pharma Industries India will hold a meeting of the Board of Directors of the Compan...

Read more

12 Nov 2024 10:10

News

Saroja Pharma Industries India schedules AGM

Saroja Pharma Industries India announced that the 6th Annual General Meeting (AGM) of the ...

Read more

10 Sep 2024 11:31

News

Saroja Pharma Industries India announces board meeting date

Saroja Pharma Industries India will hold a meeting of the Board of Directors of the Compan...

Read more

24 May 2024 18:53

News

Saroja Pharma Industries India to convene board meeting

Saroja Pharma Industries India will hold a meeting of the Board of Directors of the Compan...

Read more

07 Nov 2023 17:17

News

NSE SME Saroja Pharma Industries lists at discount

The scrip was listed at Rs 65, a discount of 22.62% compared with the issue price. The scr...

Read more

13 Sep 2023 11:00

Vadilal Enterprises Ltd News Hub

News

Board of Vadilal Enterprises recommends final dividend

Vadilal Enterprises announced that the Board of Directors of the Company at its meeting he...

Read more

27 May 2025 11:36

News

Vadilal Enterprises to discuss results

Vadilal Enterprises will hold a meeting of the Board of Directors of the Company on 26 May...

Read more

21 May 2025 18:26

News

Vadilal Enterprises schedules board meeting

Vadilal Enterprises will hold a meeting of the Board of Directors of the Company on 31 Jan...

Read more

23 Jan 2025 10:05

News

Vadilal Enterprises to convene board meeting

Vadilal Enterprises will hold a meeting of the Board of Directors of the Company on 14 Nov...

Read more

07 Nov 2024 20:54

News

Vadilal Enterprises schedules AGM

Vadilal Enterprises announced that the 39th Annual General Meeting (AGM) of the company wi...

Read more

12 Aug 2024 15:31

News

Vadilal Enterprises announces board meeting date

Vadilal Enterprises will hold a meeting of the Board of Directors of the Company on 6 Augu...

Read more

26 Jul 2024 16:23

SWOT Analysis Of Saroja Pharma Industries India Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Vadilal Enterprises Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Saroja Pharma Industries India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Vadilal Enterprises Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Saroja Pharma Industries India Ltd and Vadilal Enterprises Ltd

Which company has a larger market capitalization, Saroja Pharma Industries India Ltd or Vadilal Enterprises Ltd?

Market cap of Saroja Pharma Industries India Ltd is 16 Cr while Market cap of Vadilal Enterprises Ltd is 891 Cr

What are the key factors driving the stock performance of Saroja Pharma Industries India Ltd and Vadilal Enterprises Ltd?

The stock performance of Saroja Pharma Industries India Ltd and Vadilal Enterprises Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Saroja Pharma Industries India Ltd and Vadilal Enterprises Ltd?

As of July 22, 2025, the Saroja Pharma Industries India Ltd stock price is INR ₹40.0. On the other hand, Vadilal Enterprises Ltd stock price is INR ₹10363.6.

How do dividend payouts of Saroja Pharma Industries India Ltd and Vadilal Enterprises Ltd compare?

To compare the dividend payouts of Saroja Pharma Industries India Ltd and Vadilal Enterprises Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions